By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix today reported $85 million in preliminary revenue for the fourth quarter — a 6 percent increase over $78.6 million in the fourth quarter of 2009.

The company said that its anticipated fourth-quarter 2010 revenue includes a $4.8 million milestone payment from an undisclosed diagnostic partner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.

Wired writes that CRISPR could change the world — in many imaginative ways — and whether it will be for the better is still in the air.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.